Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.

Blood Adv · 2025 · PMC12018988 · PMID 39951615

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally nonsignificantno p-value reported

However, because evidence for a difference was weak but marginally nonsignificant, we performed a post hoc pairwise comparison to examine possible differences between groups.

also in 149 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.